Please read this new announcement regarding updated forecasting data. Click here to read

Research Articles

A Primer on Valuation: Testing the Wisdom of Ben Graham’s Formula

2011-02-09

Research Articles

If an investor is going to successfully invest in common stocks over their lifetime, there are three important questions that must be correctly answered. What to invest in? When to invest? When to sell? The first question deals with finding the right company or companies that you believe can deliver the returns you are seeking. […]

Ben Graham’s Stock Valuing Formula: It Really Works

2011-02-09

Research Articles

Ben Graham’s famed formula for valuing a stock works in the real world! V* = EPS x (8.5 + 2g) Ten Real World examples of companies growing between zero and 5% These ten examples are based on our article: “A primer on valuation: Testing the Wisdom of Ben Graham’s Formula” (part one) published on 2/08/2011. […]

A Primer on Valuation: Testing the Wisdom of Ben Graham’s Formula

2011-02-09

Research Articles

If an investor is going to successfully invest in common stocks over their lifetime, there are three important questions that must be correctly answered. What to invest in? When to invest? When to sell? The first question deals with finding the right company or companies that you believe can deliver the returns you are seeking. […]

Hudson City Bancorp: Short-Term Risk, Long-Term Opportunity?

2011-01-29

Research Articles

Hudson City Bancorp (HCBK) is widely recognized as one of the most conservatively and best managed financial institutions in the country. Thanks to their conservative lending practices and prudent fiscal management, Hudson City Bancorp prospered through the great recession while other financial institutions faltered and even collapsed. This prudently run financial institution did not partake […]

Would Ben Graham Give Warren Buffett an ‘F’ for Holding Coca-Cola?

2011-01-21

Research Articles

As most everyone knows, Warren Buffett received much of his initial investing education from the father of modern security analysis, the venerable Ben Graham. Personally, I attribute most everything I know about investing from reading the teachings of both Graham and Buffett. To me, it only made sense to learn as much as I could […]

Teva Pharmaceutical Has It All: Value, Growth and Yield

2011-01-15

Research Articles

Headquartered in Israel, Teva (TEVA) is the world’s largest generic drug maker, which markets over 1200 molecules in over 60 countries throughout the world. In addition to their generic portfolio, Teva also possesses a strong branded portfolio led by Copaxone, the world’s leading injectable therapy for multiple sclerosis. Teva generates high levels of cash flow, […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.